Bluebird Bio reported $0 in Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Agios Pharmaceuticals AGIO:US $ 0.53M 0.08M
Alnylam Pharmaceuticals ALNY:US $ 676.71M 1.01M
Amgen AMGN:US $ 36854M 3545M
Applied Genetic Technologies AGTC:US $ 20.43M 0.16M
Arrowhead Research ARWR:US $ 0M 0M
Avrobio Inc AVRO:US $ 15.02M 75K
Biogen BIIB:US $ 7275.2M 2.1M
Biomarin Pharmaceutical BMRN:US $ 1080.06M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Gilead Sciences GILD:US $ 26208M 487M
Immunogen IMGN:US $ 0M 0M
Intercept Pharmaceuticals ICPT:US $ 716.88M 177.1M
IONIS PHARMACEUT IONS:US $ 1252.14M 23.19M
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US 806M 42M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NOVN:VX SF 31275M 250M
Pfizer PFE:US $ 36301M 2135M
Ptc Therapeutics PTCT:US $ 1197.09M 8.62M
Regeneron Pharmaceuticals REGN:US $ 2700.4M 0.7M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1098.85M 1.97M
Seattle Genetics SGEN:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0.98M
Vertex Pharmaceuticals VRTX:US $ 495.5M 14.3M
YTE INCY:US $ 34.18M 0.09M